XML 106 R94.htm IDEA: XBRL DOCUMENT v3.20.2
Shareholders' Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Sep. 04, 2019
Jan. 31, 2020
Dec. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Jan. 29, 2019
Jan. 22, 2019
Jan. 20, 2019
Jan. 12, 2019
Shareholders' Equity (Textual)                  
Common stock, shares authorized     300,000,000 300,000,000          
Common stock, shares issued     128,326,243 128,846,064          
Common stock, shares outstanding     128,326,243 128,846,064          
Preferred shares, authorised     100,000,000 100,000,000          
Preferred shares, issued              
Preferred shares, outstanding              
Shares of common stock redeemed 100,000                
Value of common stock redeemed $ 50,000                
Price per share $ 0.50         $ 0.0001 $ 0.0001 $ 0.0001 $ 0.0001
Description of warrants     The Company had outstanding warrants to purchase an aggregate of 503,523 shares of common stock. Of those 503,523 warrants, 283,523 had an exercise price of $0.01 per share; 70,000 had an exercise price of $5.00 per share; 100,000 had an exercise price of $1.00 per share; and the remaining 50,000 had an exercise price of $0.50 per share.            
Description of consulting agreement   The Company entered into an agreement with a consultant to its subsidiary, Lextrum, to amend a consulting agreement between the consultant and Lextrum to allow the consultant to elect to take from 50% to 100% of its compensation in the form of common stock of the Company. Common stock to be issued to the consultant will be paid on a quarterly basis. On March 12, 2020, the Company issued 165,095 shares of its common stock in satisfaction of $106,238 that was owed by Lextrum to the consultant for services previously rendered. The fair value on the issue date of the 165,095 shares was $193,160. The Company booked the difference between the fair value of the shares issued and the amount owed by Lextrum to the consultant as general and administrative expense in the Company's Condensed Consolidated Financial Statements. To date, no additional shares of common stock have been issued pursuant to this agreement.              
Preferred Series A [Member]                  
Shareholders' Equity (Textual)                  
Common stock, shares authorized         300,000,000        
Common stock, shares outstanding         41,207,149        
Preferred shares, authorised         5,000,000        
Preferred shares, issued         2,600,000        
Preferred shares, outstanding         2,600,000